RXi Pharmaceuticals Corporation (RXII) tumbled -9.36% or -0.05 to $0.47. It is approximately 2.24 million shares traded, which is 571.14% compare to the average total volume 392740. The market cap of RXII is $11.04 million. The year to date change is -6.55%. The 52 week price range is from $0.32 to $1.12. Price of RXII have changed -6.56% during last week. It have changed -12.90% over last month, 18.13% over last 3 months, -16.99% over last 6 months and -28.62% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for RXII is 0.59. It is 25.53% above current price. The 200-day Moving Averages for RXII is 0.60. It is 27.66% above current price. The 52-week High is 1.12. It is 138.30% from the current price. The 52-week Low is 0.32. It is -31.91% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of RXII is 4.91 on 2017-12-15. Short % to float is 7.41%. There are some statistics of RXII. It is has market cap $11.04 million. The share outstanding is 23.70 million. The average volume is 392740. The percent of top 15 Institution holding is 3.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of RXII is -450.36%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of RXII is -266.57%.